Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
AI-driven cell analysis platform delivers earlier insights for bioprocessing and manufacturing
New platform capabilities unite experimentation, evaluation, deployment and monitoring in one governed workflow to rapidly move agentic AI applications to production with confidence
Detecting the presence of undesirable microbes is an integral step in maintaining quality and safety at Coca-Cola
Providing researchers with expanded capabilities in interrogating the tissue microenvironment
Azenta Life Sciences presents Ultra Optically Clear assay plates, for DNA purity measurements
KNAUER’s high-pressure, two-piston dosing pumps provide high accuracy for processing applications in the pharmaceutical and chemical industries as well as for analysis in research and development.
electronRx’s proprietary suite of digital solutions is dedicated to improving the lives of people with breathing disorders using smartphone technology to measure changes in cardiac and pulmonary functions to support them in making informed interventions
Switch Seamlessly from Your Current Dual-Luciferase® Assay!
A breakthrough in sample automation and concentration for GC–MS
From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer
A single modular, versatile, effortless and sensitive IonQuest ion chromatography system
The 1260 Infinity III SFC Control Module is a carbon dioxide conditioning unit for supercritical fluid chromatography. This module pre- and postconditions CO2 for InfinityLab SFC solutions. CO2 preconditioning provides for unmatched stability and precision of retention times, and postconditioning enables trouble-free connection to mass spectrometers.
The Thermo Scientific FAIMS Pro Duo interface extends differential ion mobility capability to multiple Thermo Scientific next-generation mass spectrometers
Data presented at the AACR 2026 revealed a 44% reduction and growing urban concentration of U.S. phase I NSCLC trial sites between 2020 and 2024
The new headspace sampler by Shimadzu provides high-performance and user-friendly analysis
Advancement can enable greater certainty for providers and better outcomes for patients
